MoonLake Immunotherapeutics (MLTX) Tax Rate (2021 - 2026)
MoonLake Immunotherapeutics (MLTX) recorded quarterly Tax Rate of 0.9% in Q1 2026, down 127.88% quarter-over-quarter from 0.4% in Q4 2025, and down 52.0% on a YoY basis from 1.88% in Q1 2025.
MoonLake Immunotherapeutics (MLTX) Tax Rate (2021 - 2026) Analysis & Trends
MoonLake Immunotherapeutics' Tax Rate history runs 6 years deep, the most recent figure standing at 0.9% for Q1 2026.
- In Q1 2026, Tax Rate fell 52.0% year-over-year to 0.9%; the TTM figure through Mar 2026 stood at 0.42% (down 17.0% YoY), while the FY2025 annual figure was 0.27%, down 3.0% from the prior year.
- Tax Rate was 0.9% for Q1 2026 at MoonLake Immunotherapeutics, down from 0.4% in the prior quarter.
- In the past five years, Tax Rate ranged from a high of 0.05% in Q1 2022 to a low of 0.9% in Q1 2026.
- Historically, Tax Rate has averaged 0.26% across 5 years, with a median of 0.17% in 2025.
- The sharpest annual moves came in 2024 and 2026: Tax Rate surged 47 bps in 2024, then slumped 52 bps in 2026.
- A 5-year view of Tax Rate shows it stood at 0.07% in 2022, then sank by 737 bps to 0.56% in 2023, then jumped by 84 bps to 0.09% in 2024, then plunged by 347 bps to 0.4% in 2025, then plunged by 128 bps to 0.9% in 2026.
- The last three Tax Rate figures came in at 0.9% (Q1 2026), 0.4% (Q4 2025), and 0.16% (Q3 2025), per Business Quant data.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Tax Rate (Qtr) |
|---|---|---|---|---|---|
| 1 | Alterity Therapeutics | 788,338.31 Bn | 788,338.28 Bn | - | - |
| 2 | Belite Bio | 56,560.00 Bn | 56,560.00 Bn | - | - |
| 3 | Quantum Biopharma | 17,329.30 Bn | 17,329.30 Bn | - | - |
| 4 | Legend Biotech | 3,341.00 Bn | 3,340.71 Bn | 242.10 Mn | -57.14% |
| 5 | Akari Therapeutics | 1,727.91 Bn | 1,727.91 Bn | - | 5.61% |
| 6 | Evaxion A | 1,536.68 Bn | 1,536.67 Bn | - | -6.79% |
| 7 | Psyence Biomedical | 238.34 Bn | 238.33 Bn | - | - |
| 8 | Vertex Pharmaceuticals | 113.42 Bn | 106.17 Bn | 2.59 Bn | 17.68% |
| 9 | Abivax | 95.45 Bn | 95.45 Bn | - | - |
| 10 | MoonLake Immunotherapeutics | 1.27 Bn | 910.04 Mn | - | -0.90% |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | -0.90% |
| Mar 31, 2026 | -0.90% |
| Dec 31, 2025 | -0.40% |
| Dec 31, 2025 | -0.40% |
| Sep 30, 2025 | -0.16% |
| Sep 30, 2025 | -0.16% |
| Jun 30, 2025 | -0.17% |
| Jun 30, 2025 | -0.17% |
| Mar 31, 2025 | -0.38% |
| Mar 31, 2025 | -0.38% |
| Dec 31, 2024 | -0.09% |
| Dec 31, 2024 | -0.09% |
| Sep 30, 2024 | -0.26% |
| Sep 30, 2024 | -0.26% |
| Jun 30, 2024 | -0.32% |
| Jun 30, 2024 | -0.32% |
| Mar 31, 2024 | -0.50% |
| Mar 31, 2024 | -0.50% |
| Dec 31, 2023 | -0.56% |
| Dec 31, 2023 | -0.56% |